Alessandra Porto de Macedo Costa

Dr. Alessandra Porto de Macedo Costa


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2022 in Viruses
Verified
Journal Article
Open access
PDF file
ACAlessandra Porto de Macedo Costa
Alessandra Porto de Macedo Costa
MSMarcos Antonio Custódio Neto da Silva
Marcos Antonio Custódio Neto da Silva
RCRogerio Soares Castro
Rogerio Soares Castro
ASAna Leatrice de Oliveira Sampaio
Ana Leatrice de Oliveira Sampaio
AJAntônio Machado Alencar Júnior
Antônio Machado Alencar Júnior
AFAdalgisa de Souza Paiva Ferreira
Adalgisa de Souza Paiva Ferreira
This study aims to evaluate the accuracy of the PAGE-B and REACH-B scores in predicting the risk of developing HCC in patients with chronic hepatitis B regularly followed up at a reference service in the State of Maranhão. A historical, longitudinal, retrospective cohort study, carried out from the review of medical records of patients with chronic Hepatitis B. PAGE-B and REACH-B scores were calculated and the accuracy of the scores in predicting the risk of HCC in the studied population was evaluated. A total of 978 patients were included, with a median age of around 47 years, most of them female and not cirrhotic. HCC was identified in 34 patients. Thrombocytopenia, high viral load, male gender and age were associated with the occurrence of HCC. The ROC curve for the PAGE-B score showed a value of 0.78 and for the REACH-B score of 0.79. The cutoff point for PAGE-B was 11 points for greater sensitivity and for REACH-B 7.5 points considering greater sensitivity and 9.5 points considering greater specificity. PAGE-B and REACH-B scores were able to predict the risk of developing HCC in the studied population. The use of risk stratification scores is useful to reduce costs associated with HCC screening.